鳥インフルエンザ治療の世界市場レポート 2025年

鳥インフルエンザ治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.3％で196億9,000万米ドルに成長します。予測期間における成長の背景には、意識と診断の高まり、パンデミック対策に向けた政府の取り組み、研究開発投資の増加、鳥インフルエンザに対する効果的な治療薬の必要性、広範な研究開発努力があります。予測期間における主な動向としては、新規治療アプローチの開発、将来の技術革新、共同研究への取り組み、新規事業開発、投資機会、遠隔医療や遠隔診察の導入などが挙げられます。

認知度の向上と診断の改善が、今後の鳥インフルエンザ治療市場の拡大を牽引すると予測されます。認知には状態を認識することが含まれ、診断にはその認知に基づいて特定の問題を特定することが含まれます。鳥インフルエンザ治療の需要は、公衆衛生を守り、潜在的なパンデミックを予防し、家禽集団を経済的損失から守る緊急の必要性から生じています。効果的な鳥インフルエンザ治療のためには、認知度と早期診断が不可欠であり、迅速な介入と病気の拡大を防ぐ封じ込めを可能にします。例えば、スイスに本部を置く政府間機関である世界保健機関（WHO）は2024年4月、HPAI A（H5N1）ウイルスに感染していると思われる動物に暴露された米国内の8,000人以上が、2022年2月9日から2024年3月29日までアクティブサーベイランス下にあったと報告しました。このように、意識の高まりと診断が鳥インフルエンザ治療市場の成長を促進しています。

鳥インフルエンザ治療市場の主要企業は、有効性を向上させ、新しい治療法の市場開拓を加速させるためにパートナーシップを重視しています。このようなパートナーシップは、製薬企業、研究機関、政府機関が協力してリソースをプールし、専門知識を共有し、革新的な臨床試験を実施するものです。例えば、2024年4月、ドイツに本社を置くバイオテクノロジー企業CureVac N.V.は、英国に本社を置く製薬会社GSK plcと提携し、プレパンデミック・インフルエンザA（H5N1）ワクチン候補を開発しました。この提携は、H5N1鳥インフルエンザウイルスが将来もたらすパンデミックの脅威に対処することを目的としており、CureVac社独自の第2世代mRNA技術を用いた一価ワクチン候補の安全性、反応原性、免疫原性を評価します。併用フェーズ1/2試験では、18歳から64歳の健康な成人および65歳から85歳の高齢者を対象に、ワクチン候補の安全性と有効性を評価します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界鳥インフルエンザ治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の鳥インフルエンザ治療市場：成長率分析
• 世界の鳥インフルエンザ治療市場の実績：規模と成長, 2019-2024
• 世界の鳥インフルエンザ治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界鳥インフルエンザ治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の鳥インフルエンザ治療市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• ワクチン
• 抗ウイルス剤
• 免疫グロブリン
• 世界の鳥インフルエンザ治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン薬局
• オフライン薬局
• 世界の鳥インフルエンザ治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 施設保健センター
• クリニック
• 世界の鳥インフルエンザ治療市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 広域スペクトル抗生物質
• テトラサイクリン系抗生物質
• ペニシリン系抗生物質
• マクロライド系抗生物質
• セファロスポリン
• 抗菌ペプチド
• 世界の鳥インフルエンザ治療市場、ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ワクチン
• 生弱毒化ワクチン
• 組み換えワクチン
• サブユニットワクチン
• DNAワクチン
• 二価ワクチンと多価ワクチン
• 世界の鳥インフルエンザ治療市場抗ウイルス剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ノイラミニダーゼ阻害剤（オセルタミビル、ザナミビル）
• M2イオンチャネル阻害剤（アマンタジン）
• ポリメラーゼ阻害剤
• プロテアーゼ阻害剤
• 抗ウイルス併用療法
• 世界の鳥インフルエンザ治療市場免疫グロブリンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒト免疫グロブリン（Ivig）
• モノクローナル抗体
• ハイパーイミュンセラム
• 多価免疫グロブリン
• 鳥インフルエンザ特異的免疫グロブリン

第7章 地域別・国別分析

• 世界の鳥インフルエンザ治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の鳥インフルエンザ治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鳥インフルエンザ治療市場：競合情勢
• 鳥インフルエンザ治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Novartis AG
• GlaxoSmithKline Plc
• Gilead Sciences Inc.
• Baxter International Inc.
• CSL Limited
• Moderna Inc.
• Cipla Ltd.
• Shionogi & Co. Ltd.
• Novavax Inc.
• Seqirus Pty Ltd.
• Sinovac Biotech Ltd.
• Emergent BioSolutions Inc.
• Dynavax Technologies Corporation
• CureVac AG
• Valneva SE

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 鳥インフルエンザ治療市場2029：新たな機会を提供する国
• 鳥インフルエンザ治療市場2029：新たな機会を提供するセグメント
• 鳥インフルエンザ治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Avian flu treatment involves medical approaches and strategies aimed at managing and easing symptoms of avian influenza, commonly known as bird flu, in infected individuals. Avian influenza is caused by viruses that primarily affect birds, though certain strains such as H5N1 and H7N9 can also infect humans, leading to severe illness or even death in some cases.

The primary treatments for avian flu include antibiotics, vaccines, antiviral agents, and immunoglobulins. Antibiotics are medications designed to combat bacterial infections. These treatments are accessible through both online and offline pharmacies and are utilized by various end-users such as hospitals, institutional health centers, and clinics.

The avian flu treatment market research report is one of a series of new reports from The Business Research Company that provides avian flu treatment market statistics, including avian flu treatment industry global market size, regional shares, competitors with a avian flu treatment market share, detailed avian flu treatment market segments, market trends and opportunities, and any further data you may need to thrive in the avian flu treatment industry. This avian flu treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The avian flu treatment market size has grown strongly in recent years. It will grow from $12.59 billion in 2024 to $13.81 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increased demand for avian flu treatment, rise in measures to prevent the spread of bird flu, increased availability of treatment options, increased investment for healthcare infrastructure, and increased demand for poultry for consumption.

The avian flu treatment market size is expected to see strong growth in the next few years. It will grow to $19.69 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing awareness and diagnosis, government initiatives for pandemic preparedness, rising research and development investments, the need for effective therapeutics against avian influenza, and extensive research and development efforts. Major trends in the forecast period include the development of novel therapeutic approaches, future innovation and technologies, collaborative research efforts, new business development, and investment opportunities, and telemedicine and remote consultation implementation.

Growing awareness and improved diagnosis are anticipated to drive the expansion of the avian flu treatment market in the future. Awareness involves recognizing a condition, while diagnosis identifies a specific issue based on that awareness. The demand for avian flu treatment stems from the urgent need to protect public health, prevent potential pandemics, and shield poultry populations from substantial economic losses. Awareness and early diagnosis are vital for effective avian flu treatment, enabling prompt intervention and containment to prevent the disease from spreading. For instance, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in April 2024 that over 8,000 people in the US were under active surveillance from February 9, 2022, to March 29, 2024, after exposure to animals believed to be infected with the HPAI A (H5N1) virus. Thus, increasing awareness and diagnosis are driving the growth of the avian flu treatment market.

Leading companies in the avian flu treatment market are emphasizing partnerships to improve efficacy and accelerate the development of new treatments. These partnerships involve collaborations between pharmaceutical companies, research institutions, and government agencies to pool resources, share expertise, and conduct innovative clinical trials. For example, in April 2024, CureVac N.V., a biotechnology company based in Germany, partnered with GSK plc, a UK-based pharmaceutical company, to develop an investigational influenza A (H5N1) pre-pandemic vaccine candidate. This collaboration aims to address the potential future pandemic threat posed by the H5N1 avian influenza virus by evaluating the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which uses CureVac's proprietary second-generation mRNA technology. The combined Phase 1/2 study will assess the vaccine candidate's safety and effectiveness in healthy adults aged 18 to 64 and older adults aged 65 to 85.

In December 2022, Hester Biosciences Ltd., an Indian animal and poultry vaccine manufacturing company, acquired technology from the Indian Council of Agricultural Research and the National Institute of High-Security Animal Diseases (ICAR-NIHSAD) for an undisclosed amount. This acquisition aims to develop an inactivated H9N2 avian influenza vaccine for poultry, providing a solution to the significant economic losses experienced by Indian poultry farmers due to periodic outbreaks of the disease. The Indian Council of Agricultural Research and the National Institute of High-Security Animal Diseases (ICAR-NIHSAD) is an India-based research institute that offers technology for avian flu vaccines and diagnostic tests for avian influenza.

Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Gilead Sciences Inc., Baxter International Inc., CSL Limited, Moderna Inc., Cipla Ltd., Shionogi & Co. Ltd., Novavax Inc., Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, CureVac AG, Valneva SE, BioCryst Pharmaceuticals Inc., Siga Technologies Inc., Aridis Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Biolyse Pharma

North America was the largest region in the avian flu treatment market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the avian flu treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The avian flu treatment market consists of sales of antiviral medications, respiratory support equipment, and intravenous fluids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Avian Flu Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on avian flu treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for avian flu treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The avian flu treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Antibiotics; Vaccines; Antiviral Agents; Immunoglobulins
• 2) By Distribution Channel: Online Pharmacies; Offline Pharmacies
• 3) By End User: Hospital; Institutional Health Centers; Clinics
• Subsegments:
• 1) By Antibiotics: Broad-Spectrum Antibiotics; Tetracycline Antibiotics; Penicillin-Based Antibiotics; Macrolide Antibiotics; Cephalosporins; Antimicrobial Peptides
• 2) By Vaccines: Inactivated Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Subunit Vaccines; Dna Vaccines; Bivalent And Multivalent Vaccines
• 3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir); M2 Ion Channel Inhibitors (Amantadine); Polymerase Inhibitors; Protease Inhibitors; Antiviral Combination Therapies
• 4) By Immunoglobulins: Human Immunoglobulin (Ivig); Monoclonal Antibodies; Hyperimmune Serum; Polyvalent Immunoglobulins; Avian Flu-Specific Immunoglobulins
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Avian Flu Treatment Market Characteristics

3. Avian Flu Treatment Market Trends And Strategies

4. Avian Flu Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Avian Flu Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Avian Flu Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Avian Flu Treatment Market Growth Rate Analysis
• 5.4. Global Avian Flu Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Avian Flu Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Avian Flu Treatment Total Addressable Market (TAM)

6. Avian Flu Treatment Market Segmentation

• 6.1. Global Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Vaccines
• Antiviral Agents
• Immunoglobulins
• 6.2. Global Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Pharmacies
• Offline Pharmacies
• 6.3. Global Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Institutional Health Centers
• Clinics
• 6.4. Global Avian Flu Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Broad-Spectrum Antibiotics
• Tetracycline Antibiotics
• Penicillin-Based Antibiotics
• Macrolide Antibiotics
• Cephalosporins
• Antimicrobial Peptides
• 6.5. Global Avian Flu Treatment Market, Sub-Segmentation Of Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Subunit Vaccines
• Dna Vaccines
• Bivalent And Multivalent Vaccines
• 6.6. Global Avian Flu Treatment Market, Sub-Segmentation Of Antiviral Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuraminidase Inhibitors (Oseltamivir, Zanamivir)
• M2 Ion Channel Inhibitors (Amantadine)
• Polymerase Inhibitors
• Protease Inhibitors
• Antiviral Combination Therapies
• 6.7. Global Avian Flu Treatment Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Immunoglobulin (Ivig)
• Monoclonal Antibodies
• Hyperimmune Serum
• Polyvalent Immunoglobulins
• Avian Flu-Specific Immunoglobulins

7. Avian Flu Treatment Market Regional And Country Analysis

• 7.1. Global Avian Flu Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Avian Flu Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Avian Flu Treatment Market

• 8.1. Asia-Pacific Avian Flu Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Avian Flu Treatment Market

• 9.1. China Avian Flu Treatment Market Overview
• 9.2. China Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Avian Flu Treatment Market

• 10.1. India Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Avian Flu Treatment Market

• 11.1. Japan Avian Flu Treatment Market Overview
• 11.2. Japan Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Avian Flu Treatment Market

• 12.1. Australia Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Avian Flu Treatment Market

• 13.1. Indonesia Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Avian Flu Treatment Market

• 14.1. South Korea Avian Flu Treatment Market Overview
• 14.2. South Korea Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Avian Flu Treatment Market

• 15.1. Western Europe Avian Flu Treatment Market Overview
• 15.2. Western Europe Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Avian Flu Treatment Market

• 16.1. UK Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Avian Flu Treatment Market

• 17.1. Germany Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Avian Flu Treatment Market

• 18.1. France Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Avian Flu Treatment Market

• 19.1. Italy Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Avian Flu Treatment Market

• 20.1. Spain Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Avian Flu Treatment Market

• 21.1. Eastern Europe Avian Flu Treatment Market Overview
• 21.2. Eastern Europe Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Avian Flu Treatment Market

• 22.1. Russia Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Avian Flu Treatment Market

• 23.1. North America Avian Flu Treatment Market Overview
• 23.2. North America Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Avian Flu Treatment Market

• 24.1. USA Avian Flu Treatment Market Overview
• 24.2. USA Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Avian Flu Treatment Market

• 25.1. Canada Avian Flu Treatment Market Overview
• 25.2. Canada Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Avian Flu Treatment Market

• 26.1. South America Avian Flu Treatment Market Overview
• 26.2. South America Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Avian Flu Treatment Market

• 27.1. Brazil Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Avian Flu Treatment Market

• 28.1. Middle East Avian Flu Treatment Market Overview
• 28.2. Middle East Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Avian Flu Treatment Market

• 29.1. Africa Avian Flu Treatment Market Overview
• 29.2. Africa Avian Flu Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Avian Flu Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Avian Flu Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Avian Flu Treatment Market Competitive Landscape And Company Profiles

• 30.1. Avian Flu Treatment Market Competitive Landscape
• 30.2. Avian Flu Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

31. Avian Flu Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. GlaxoSmithKline Plc
• 31.3. Gilead Sciences Inc.
• 31.4. Baxter International Inc.
• 31.5. CSL Limited
• 31.6. Moderna Inc.
• 31.7. Cipla Ltd.
• 31.8. Shionogi & Co. Ltd.
• 31.9. Novavax Inc.
• 31.10. Seqirus Pty Ltd.
• 31.11. Sinovac Biotech Ltd.
• 31.12. Emergent BioSolutions Inc.
• 31.13. Dynavax Technologies Corporation
• 31.14. CureVac AG
• 31.15. Valneva SE

32. Global Avian Flu Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Avian Flu Treatment Market

34. Recent Developments In The Avian Flu Treatment Market

35. Avian Flu Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Avian Flu Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Avian Flu Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Avian Flu Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer